Semaglutides are a widely used category of medication used to increase insulin production and reduce blood sugar. While they are mostly prescribed to diabetics, they are also used to promote weight loss. From 2015 to 2020, 51.1% of US adults, or around 43.3 million people, met the FDA eligibility criteria for semaglutide according to the National Library of Medicine, meaning they had a body mass index of at least 27 and had at least one weight-related condition.
Those taking semaglutide and weight loss medications have reported suffering severe side effects, often requiring hospitalization for their injuries. Victims are taking legal action against the manufacturers for these dangers and pursuing justice for their injuries.